Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan
· Delayed Price · Currency is TWD 30.00
-0.05 (-0.17%)
Jun 6, 2025, 1:30 PM CST
TPEX:4111 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 1,709 | 1,584 | 1,519 | 1,544 | 1,316 | 1,365 | Upgrade
|
| Market Cap Growth | 4.32% | 4.32% | -1.66% | 17.32% | -3.55% | -3.62% | Upgrade
|
| Enterprise Value | 1,400 | 1,313 | 1,268 | 1,425 | 1,261 | 1,093 | Upgrade
|
| Last Close Price | 30.00 | 27.80 | 25.67 | 24.96 | 20.42 | 20.24 | Upgrade
|
| PE Ratio | 15.54 | 14.32 | 22.11 | 10.03 | 16.30 | 23.08 | Upgrade
|
| Forward PE | - | 14.56 | 14.56 | 14.56 | 14.56 | 14.56 | Upgrade
|
| PS Ratio | 1.47 | 1.36 | 1.43 | 1.35 | 1.29 | 1.39 | Upgrade
|
| PB Ratio | 1.34 | 1.24 | 1.25 | 1.26 | 1.20 | 1.27 | Upgrade
|
| P/TBV Ratio | 1.34 | 1.24 | 1.25 | 1.26 | 1.20 | 1.27 | Upgrade
|
| P/FCF Ratio | 13.25 | 12.28 | - | 14.10 | - | 11.23 | Upgrade
|
| P/OCF Ratio | 8.02 | 7.43 | 20.38 | 7.19 | 9.45 | 9.51 | Upgrade
|
| EV/Sales Ratio | 1.20 | 1.13 | 1.20 | 1.25 | 1.23 | 1.12 | Upgrade
|
| EV/EBITDA Ratio | 8.47 | 7.95 | 10.29 | 6.50 | 6.61 | 7.17 | Upgrade
|
| EV/EBIT Ratio | 14.15 | 13.27 | 20.71 | 9.26 | 10.60 | 14.46 | Upgrade
|
| EV/FCF Ratio | 10.85 | 10.18 | - | 13.01 | - | 8.99 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.10 | 0.11 | 0.13 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.16 | 0.16 | 1.00 | 0.57 | 0.73 | 0.08 | Upgrade
|
| Debt / FCF Ratio | 0.21 | 0.21 | - | 1.17 | - | 0.10 | Upgrade
|
| Asset Turnover | 0.66 | 0.66 | 0.60 | 0.66 | 0.65 | 0.65 | Upgrade
|
| Inventory Turnover | 8.26 | 8.26 | 7.63 | 7.61 | 7.58 | 7.68 | Upgrade
|
| Quick Ratio | 1.83 | 1.83 | 1.57 | 1.54 | 1.20 | 2.00 | Upgrade
|
| Current Ratio | 2.11 | 2.11 | 1.78 | 1.78 | 1.46 | 2.34 | Upgrade
|
| Return on Equity (ROE) | 8.87% | 8.87% | 5.63% | 15.44% | 9.90% | 5.51% | Upgrade
|
| Return on Assets (ROA) | 3.52% | 3.52% | 2.15% | 5.56% | 4.73% | 3.14% | Upgrade
|
| Return on Capital (ROIC) | 4.68% | 4.68% | 2.84% | 7.41% | 6.38% | 4.34% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.20% | 7.20% | 4.70% | 11.70% | 9.80% | 6.30% | Upgrade
|
| Earnings Yield | 6.47% | 6.98% | 4.52% | 9.97% | 6.13% | 4.33% | Upgrade
|
| FCF Yield | 7.55% | 8.14% | -1.78% | 7.09% | -9.54% | 8.91% | Upgrade
|
| Dividend Yield | 3.33% | 3.60% | 3.90% | 4.81% | 4.90% | 4.94% | Upgrade
|
| Payout Ratio | 51.51% | 51.51% | 99.57% | 37.00% | 70.57% | 96.35% | Upgrade
|
| Buyback Yield / Dilution | -0.12% | -0.12% | 0.16% | -0.06% | -0.10% | 0.01% | Upgrade
|
| Total Shareholder Return | 3.21% | 3.48% | 4.06% | 4.74% | 4.80% | 4.95% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.